Results from a Phase 1/2 Study of Brentuximab Vedotin in Combination with Nivolumab in Patients with Relapsed or Refractory Hodgkin Lymphoma
- Resource Type
- Abstract
- Authors
- Herrera, Alex F.; Moskowitz, Alison J.; Bartlett, Nancy L.; Vose, Julie M ; Ramchandren, Radhakrishnan; Feldman, Tatyana A; LaCasce, Ann S; Ansell, Stephen M; Moskowitz, Craig H.; Fenton, Keenan ; Ogden, Carol Anne ; Taft, David ; Zhang, Qu ; Kato, Kazunobu ; Campbell, Mary ; Advani, Ranjana H.
- Source
- In Blood 8 December 2017 130 Supplement 1:649-649
- Subject
- Language
- ISSN
- 0006-4971